Zobrazeno 1 - 10
of 25
pro vyhledávání: '"A. N. Makoveeva"'
Autor:
A. A. Smirnov, M. M. Loukianov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Maltseva, E. N. Belova, V. G. Klyashtorniy, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 18, Iss 5, Pp 502-509 (2022)
Aim. To study the clinical and anamnestic characteristics, pharmacotherapy of cardiovascular diseases (CVD) and long-term outcomes in post-COVID-19 patients with cardiovascular multimorbidity (CVMM), enrolled in the prospective hospital registry.Mate
Externí odkaz:
https://doaj.org/article/817e2415eff742668be26a442605b03d
Autor:
Yu. V. Mareev, M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. N. Makoveeva, O. V. Lerman, E. Yu. Okshina, A. A. Smirnov, M. M. Kudryavtseva, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 21, Iss 12 (2023)
Aim. To estimate the detection rate of heart failure (HF), using various diagnosis criteria, among patients aftr 12 months after hospital treatment for coronavirus disease 2019 (COVID-19).Material and methods. The study included 185 patients from the
Externí odkaz:
https://doaj.org/article/49b9b47e487a4876a7816da4c07136a4
Autor:
N. P. Kutishenko, M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, M. M. Kudryavtseva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, А. А. Smirnov, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 21, Iss 12 (2023)
Aim. To evaluate the medical treatment of patients with cardiovascular disease (CVD) during the first year of follow-up after hospitalization for coronavirus disease 2019 (COVID-19) in a prospective registry.Material and methods. The material for the
Externí odkaz:
https://doaj.org/article/bc957a2b07cf4c4fb61273111532e7ed
Autor:
M. M. Loukianov, S. Yu. Martsevich, Yu. V. Mareev, S. S. Yakushin, E. Yu. Andreenko, A. N. Vorobiev, K. G. Pereverzeva, A. V. Zagrebelny, E. Yu. Okshina, V. V. Yakusevich, Vl. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. N. Makoveeva, Yu. E. Tatsiy, S. A. Boytsov, O. M. Drapkina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 6, Pp 816-824 (2022)
Aim. To assess in clinical practice the structure of multimorbidity, cardiovascular pharmacotherapy and outcomes in patients with a combination of atrial fibrillation (AF) and chronic heart failure (CHF) based on prospective registries of patients wi
Externí odkaz:
https://doaj.org/article/68fb3be770f04a7eb88568b915ba2712
Autor:
S. Yu. Martsevich, M. M. Lukyanov, M. M. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. V. Zagrebelnyy, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. A. Smirnov, E. V. Kudryashov, I. V. Budaeva, E. S. Nikoshnova, O. E. Karpov, O. M. Drapkina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 6, Pp 873-879 (2022)
Aim. Based on the data from the register of patients with COVID-19 and community-acquired pneumonia (CAP), analyze the duration of the prehospital period, cardiovascular comorbidity and the quality of prehospital pharmacotherapy of concomitant cardio
Externí odkaz:
https://doaj.org/article/cb9215bcead442269a942fa6d59adac3
Autor:
M. M. Loukianov, S. Yu. Martsevich, E. Yu. Andrenko, S. S. Yakushin, A. N. Vorobiev, K. G. Pereverzeva, A. V. Zagrebelny, Е. Yu. Okshina, V. V. Yakusevich, Vl. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. M. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, A. N. Makoveeva, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 5, Pp 702-711 (2021)
Aim. Assess the structure of comorbid conditions, cardiovascular pharmacotherapy and outcomes in patients with atrial fibrillation (AF) and concomitant coronary artery disease (CAD) included in the outpatient and hospital RECVASA registries.Materials
Externí odkaz:
https://doaj.org/article/e9b6d3b313304148a6caa15308d1e5d5
Autor:
M. M. Lukyanov, N. P. Kutishenko, S. Yu. Martsevich, A. A. Pulin, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, A. S. Sgibneva, A. A. Smirnov, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina
Publikováno v:
Российский кардиологический журнал, Vol 27, Iss 3 (2022)
Aim. To assess long-term outcomes within 12 months after hospital treatment of patients with coronavirus disease 2019 (COVID-19) as part of a prospective registry.Material and methods. Outcomes in the posthospital period were assessed in 827 patients
Externí odkaz:
https://doaj.org/article/36d3be1415c94dc894eb470c985d985c
Autor:
M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, E. Yu. Andreenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. V. Zagrebelny, A. N. Makoveeva, O. V. Lerman, E. Yu. Okshina, А. S. Sgibneva, A. A. Smirnov, E. N. Belova, V. G. Klyashtorny, E. V. Kudryashov, O. E. Karpov, O. M. Drapkina
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 20, Iss 8 (2022)
Aim. According to hospital-based registry, to evaluate the age characteristics and prevalence of concomitant cardiovascular and non-сardiovascular diseases in patients hospitalized with COVID-19 during epidemic wave.Material and methods. The TARGET-
Externí odkaz:
https://doaj.org/article/a9c84c1a88874961a58d711139bba1fa
Autor:
E. Yu. Andreenkо, M. M. Loukianov, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, V. A. Dindikova, A. N. Makoveeva, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 16, Iss 2, Pp 258-265 (2020)
Aim. To evaluate the gender characteristics, educational level, cardiovascular diseases (CVD) risk factors and adherence to drug treatment in patients with premature CVD in an outpatient prospective registerу. Material and methods. 3690 patients wit
Externí odkaz:
https://doaj.org/article/78dd2002c84947faa0fcfc14e4b9e56b
Autor:
O. M. Drapkina, O. E. Karpov, M. M. Lukyanov, S. Yu. Martsevich, A. A. Pulin, N. P. Kutishenko, V. G. Akimkin, E. Yu. Andrenko, V. P. Voronina, V. A. Dindikova, N. A. Dmitrieva, A. V. Zagrebelny, O. V. Lerman, A. N. Makoveeva, E. Yu. Okshina, E. V. Kudryashov, V. G. Klyashtorny, A. A. Smirnov, V. S. Fomina
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 19, Iss 6 (2020)
Aim. To characterize patients admitted to hospital with suspected or documented COVID-19 infection and community-acquired pneumonia (CAP) and to assess the prevalence of concomitant cardiovascular, non-cardiac diseases, prehospital cardiovascular the
Externí odkaz:
https://doaj.org/article/c885ee9b13d747f6956b275fb0c07dab